Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

By L. Baddour, A. Epstein, C. Erickson, B. Knight, M. Levison, P. Lockhart, F. Masoudi, E. Okum, W. Wilson, L. Beerman and 6 more. Circulation, 2010

1,025 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. (2011, background): “CIED infection is associated with high patient morbidity and a mortality rate of up to 18% (8,9,16,17).”
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. (2011, background): “The management of cardiac devicerelated infections was recently reviewed in the 2010 AHA guidelines on cardiovascular implantable electronic device infections [198].”
2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. (2017, background): “Complete CIED removal should be performed when patients undergo valve replacement or repair for infective endocarditis, because the CIED could serve as a nidus for relapsing infection and subsequent seeding of the surgically treated heart valve.(153) A recent study has shown that complete CIED remov”